Advertisement
Advertisement
ANGO
AngioDynamics, Inc.
11.04
USDSponsored
+0.05
+0.49%
Mar 11, 15:59 UTC -4
Closed
After-Market
11.04
0.00
+0.01%
ANGO Earnings Reports
Positive Surprise Ratio
ANGO beat 28 of 40 last estimates.
70%
Next Report
Date of Next Report
Apr 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$78.30M
/-$0.11
Implied change from Q2 26 (Revenue/ EPS)
-1.42%
/--
Implied change from Q3 25 (Revenue/ EPS)
+8.75%
/-466.67%
AngioDynamics, Inc. earnings per share and revenue
On Jan 06, 2026, ANGO reported earnings of 0.00 USD per share (EPS) for Q2 26, beating the estimate of -0.10 USD, resulting in a 100.00% surprise. Revenue reached 79.43 million, compared to an expected 77.83 million, with a 2.06% difference. The market reacted with a -13.53% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of -0.11 USD, with revenue projected to reach 78.30 million USD, implying an -- of --% EPS, and decrease of -1.42% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Integra LifeSciences Holdings
Report Date
Feb 26, 2026 For Q4 25
Estimate
$0.81
Actual
$0.83
Surprise
+1.68%
Alpha Tau Medical Ltd. Ordinary Shares
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.12
Actual
-$0.08
Surprise
+36.51%
Neuropace, Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.15
Actual
-$0.08
Surprise
+48.22%
Sight Sciences, Inc. Common Stock
Report Date
Mar 04, 2026 For Q4 25
Estimate
-$0.14
Actual
-$0.08
Surprise
+43.66%
908 Devices Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.07
Actual
$0.10
Surprise
+240.06%
Anteris Technologies Global Corp. Common Stock
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.59
Actual
-$0.74
Surprise
-24.18%
Stereotaxis, Inc. Common Stock
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.06
Surprise
+10.04%
Treace Medical Concepts, Inc. Common Stock
Report Date
Feb 27, 2026 For Q4 25
Estimate
-$0.15
Actual
-$0.15
Surprise
+1.96%
Masimo Corporation
Report Date
Feb 26, 2026 For Q4 25
Estimate
$1.50
Actual
-Surprise
-
Teleflex Incorporated
Report Date
Feb 26, 2026 For Q4 25
Estimate
$3.77
Actual
$1.93
Surprise
-48.83%
FAQ
What were AngioDynamics, Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, AngioDynamics, Inc. reported EPS of $0.00, beating estimates by 100%, and revenue of $79.43M, 2.06% above expectations.
How did the market react to AngioDynamics, Inc.'s Q2 2026 earnings?
The stock price moved down -13.53%, changed from $13.23 before the earnings release to $11.44 the day after.
When is AngioDynamics, Inc. expected to report next?
The next earning report is scheduled for Apr 02, 2026.
What are the forecasts for AngioDynamics, Inc.'s next earnings report?
Based on 6
analysts, AngioDynamics, Inc. is expected to report EPS of -$0.11 and revenue of $78.30M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement